These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35187711)

  • 21. The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study.
    Jung S; Lee SM; Suh D; Shin HT; Suh DC
    Health Qual Life Outcomes; 2018 Sep; 16(1):180. PubMed ID: 30208968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.
    Touw CR; Hakkaart-Van Roijen L; Verboom P; Paul C; Rutten FF; Finlay AY
    Br J Dermatol; 2001 May; 144(5):967-72. PubMed ID: 11359382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in pediatric Chiari Type I malformation: the Chiari Health Index for Pediatrics.
    Ladner TR; Westrick AC; Wellons JC; Shannon CN
    J Neurosurg Pediatr; 2016 Jan; 17(1):76-85. PubMed ID: 26431245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.
    Reich K; Griffiths CE
    Arch Dermatol Res; 2008 Nov; 300(10):537-44. PubMed ID: 18784934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
    Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
    van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM
    Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis.
    van Geel MJ; Otero ME; de Jong EM; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2017 Mar; 176(3):771-776. PubMed ID: 27718521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.
    Reich K; Sinclair R; Roberts G; Griffiths CE; Tabberer M; Barker J
    Curr Med Res Opin; 2008 May; 24(5):1237-54. PubMed ID: 18355421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Life Impairment in Children and Adults with Vitiligo: A Cross-Sectional Study Based on Dermatology-Specific and Disease-Specific Quality of Life Instruments.
    Catucci Boza J; Giongo N; Machado P; Horn R; Fabbrin A; Cestari T
    Dermatology; 2016; 232(5):619-625. PubMed ID: 27603174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
    Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of psoriasis on quality of life in Iran.
    Aghaei S; Moradi A; Ardekani GS
    Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
    Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
    Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
    Abrouk M; Nakamura M; Zhu TH; Farahnik B; Koo J; Bhutani T
    J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Essential factors influencing health-related-quality of life in psoriasis.
    Rønneberg Mehren C; Clemmensen A; Boe-Hansen Dall A; Philipsen P; Gniadecki R
    J Drugs Dermatol; 2014 Mar; 13(3):246-50. PubMed ID: 24595566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].
    Ortonne JP; Shear N; Shumack S; Henninger E;
    BMC Dermatol; 2005 Dec; 5():13. PubMed ID: 16359548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice.
    Kim E; Fischer G
    Australas J Dermatol; 2021 May; 62(2):190-194. PubMed ID: 33586132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of health-related quality of life in psoriasis patients in Hungary].
    Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
    Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatology Life Quality Index In Patients Of Psoriasis And Its Correlation With Severity Of Disease.
    Khan JM; Rathore MU; Tahir M; Abbasi T
    J Ayub Med Coll Abbottabad; 2020; 32(1):64-67. PubMed ID: 32468758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.